Study of Applications of E-Test for the Detection of Beta Lactamase Producing Bacteria: E-Test for the Detection of Beta-Lactamase Producing Bacteria

Mehwish  Saleem; Zunaira  Azam; Saneela  Kausar; Hafiza Aqsa  Azam; Amina  Atiq; Jawairia  Akram; Leeza  Jameel; Zeenat  Mehmood; Sara  Hayee

doi:10.54393/pbmj.v5i4.258

Authors

Mehwish Saleem Lahore College for Women University, Lahore, Pakistan
Zunaira Azam Lahore College for Women University, Lahore, Pakistan
Saneela Kausar Lahore College for Women University, Lahore, Pakistan
Hafiza Aqsa Azam Lahore College for Women University, Lahore, Pakistan
Amina Atiq Lahore College for Women University, Lahore, Pakistan
Jawairia Akram Lahore College for Women University, Lahore, Pakistan
Leeza Jameel Lahore College for Women University, Lahore, Pakistan
Zeenat Mehmood Lahore College for Women University, Lahore, Pakistan
Sara Hayee Department of Zoology, Government Postgraduate College for Women, Samanabad, Lahore, Pakistan

DOI:

https://doi.org/10.54393/pbmj.v5i4.258

Keywords:

Antibiotic Resistance, E- Test, Beta- Lactamases, E. coli, Enterobacter, Klebsiella pneumonia

Abstract

The term antimicrobial resistance refers to the ability to resist the effects of drugs formally used to treat them and this term relates only to bacteria becoming resistant. Microorganisms which are resistant to multiple drugs are known as multidrug resistant bacteria. Methods: Most of the experimental work to study the application of E-Test for detection of lactamase producing bacteria was carried out at Pathology Laboratory of Sir Ganga Ram Hospital Lahore. While the remaining research work was done in Microbiology Laboratory of Govt. Post Graduate Islamia College Cooper Road Lahore during the study period from December 2019 to March 2020. Total 60 samples of different patients were collected from Sir Ganga Ram Hospital Lahore and most of the samples were urine (n=25), followed by Blood (n=14), Pus (n=14), and sputum (n=7). Oxidase, indole, citrate utilization, sugar fermentation (Kligler iron agar medium) and urease tests were performed for the identification bacterial strains. Results: In all of 60 samples frequency of occurrence of E. coli, Enterobacter and Klebsiella strains were 59%, 23%, 18% respectively. Most of them (n=36) were ESBLs positive and about (n=24) were ESBLs negative and their percentage were 60% and 40% respectively. Extended spectrum β-lactamase (ESBL) producing strains of Enterobacteriaceae have now become as a significant issue in hospitalized and community patients. These microorganisms are liable for many diseases, for example, urinary tract infection, septicemia, hospitalized-acquired pneumonia, intra-abdominal abscess, brain abscess and device related infections. Conclusions: The frequency of ESBL producing bacteria in most hospitals is very high especially in the hospitals where broad spectrum antibiotics are generally recommended. Among gram negative bacteria, the emergence of resistance to expanded spectrum cephalosporins has been a major concern. Many of ESBL producing bacteria showed multidrug resistance.

References

Majda, Q., Najma, A., Summyia, B. 2013. Evaluation of extended spectrum beta-lactamase mediated resistance in Escherichia coli and Klebsiella in urinary tract infection at a tertiary care hospital. Biomedical Journal. 29: 78-81.

John, C., Christenson, Ryan, F., Relich. 2018. Principles and Practice of Pediatric Infectious Diseases.5th ed. Elsevier Health Science. pp. 201-210.

Sibhghatulla, S., Jamale, F., Shazi, S., Syed, M., Danish, R., Mohammad, A. K. (2015). Anitibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi Journal of Biological Sciences Vol. 22 (1): 90-101.

https://doi.org/10.1016/j.sjbs.2014.08.002

Alsterlund, R., Carlsson, B., Gezelius, L., Haeggman, S.B. 2009. OlssonLiljequist Multi resistant CTX-M-15 ESBL-producing Escherichia coli in southern Sweden: description of an outbreak Scand. Journal of Infectious Diseases. 41 (67): 410-415.

https://doi.org/10.1080/00365540902896079

Goldstein, F.W. 2007. Comparison of E-test with agar dilution for testing the susceptibility of P. aeruginosa and other MDR bacteria to Colistin. Journal of chemotherapy and antimicrobial agents. 59 (5): 1039-1040.

https://doi.org/10.1093/jac/dkm046

P.A. Bradford. 2001. Extended spectrum beta-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clinical Microbiology Reviews. 14: 936-949.

https://doi.org/10.1128/CMR.14.4.933-951.2001

David J., Hetem. Miquel B., Ekkelenkamp. 2017. In Infectious Diseases. 4th ed. Jonathan Cohen, William G. Powderly and Steven M. pp. 42-43.

Fatemeh, A., Emran, A., Elnaz, K., Mohammad J., G. S., Mahboubeh, N. 2012. The frequency of extended spectrum beta lactamase (ESBL) in Escherichia coli and Klebsiella pneumonia: a report from Mashhad, Iran. Journal of medical bacteriology. 1 (3): 12-19.

Bonomo, R. A. 2017. beta-Lactamases a focus on current challenges. Cold Spring Harb Perspect in Medicine. 1 (7): 025-239.

https://doi.org/10.1101/cshperspect.a025239

Paterson, D.L., Bonomo, R.A. 2005. Extended-S.pectrum β-Lactamases: a Clinical Update. Clinical Microbiology Reviews. 18 (4): 657-686.

https://doi.org/10.1128/CMR.18.4.657-686.2005

Kaftandzhieva, A., Kotevska, V., Jankoska, G., Trajkovska, B. K., Cekovska, Z. and Petrovska, M. 2009. Extended-Spectrum Beta-Lactamase-Producing E. coli and Klebsiella Pneumoniae in Children at University Pediatric Clinic in Skopje. Macedonian Journal Medical Sciences. 2 (1): 36-41.

https://doi.org/10.3889/MJMS.1857-5773.2009.0030

Chayakulkeeree, M., Junsriwong, P., Keerasuntonpong, A., Tribuddharat, C. and Thamlikitkul, V. 2005. Epidemiology of extended-spectrum beta-lactamase producing gram negative bacilli at Siriraj hospital, Thailand 2003. Southeast Asian Journal of tropical medicine and public health. 36 (6): 1503-1509.

Tumbarello, M., Sanguinetti, M., Montuori, E., Trecarichi, E. M., Posteraro, B., Fiori, B., Citton, R., D'Inzeo, T., Fadda, G., Cauda, R. and Spanu, T. 2007. Predictors of mortality in patients with bloodstream infections caused by extended spectrum beta-lactamase producing Enterobacteriaceae: Importance of inadequate initial antimicrobial treatment. Antimicrobial Agents and Chemotherapy. 51: 1987-1994. https://doi.org/10.1128/AAC.01509-06

Tankhiwale, S. S. and Jalgaonkar, S. V. 2004. Evaluation of extended spectrum beta lactamase in urinary isolates. Indian Journal of Medical Research. 120 (6): 553-6.

Ramazanzadeh, R. 2010. Etiologic agents and extended-spectrum betalactamase production in urinary tract infections in Sanandaj, Iran. Eastern Journal Medicine. 15 (4): 57-62.

Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159–66. doi: 10.1016/S1473-3099(08)70041-0.

Feizabadi MM, Delfani S, Raji N, Majnooni A, Aligholi M, Shahcheraghi F, et al. Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran. Microb Drug Resist. 2010;16(1):49–53. DOI: 10.1089/mdr.2009.0096.

Gashe, F., Mulisa, E., Mekonnen, M., & Zeleke, G. (2018). Antimicrobial ResistanceProfile of Different Clinical Isolates against Third-Generation Cephalosporins. Journal of pharmaceutics, 2018, 5070742. https://doi.org/10.1155/2018/5070742

Hamidian M, Tajbakhsh M, Walther-Rasmussen J, Zali MR. The emergence of extended-spectrum beta-lactamases in clinical isolates of Salmonella enterica in Tehran, Iran. Jpn J Infect Dis. 2009;62(5):368–71.

Tajbakhsh M, Garcia Migura L, Rahbar M, Svendsen CA, Mohammadzadeh M, Zali MR, et al. Antimicrobial-resistant Shigella infections from Iran: an overlooked problem? J Antimicrob Chemother. 2012;67(5):1128–33. DOI: 10.1093/jac/dks023.

Ensor VM, Jamal W, Rotimi VO, Evans JT, Hawkey PM. The predominance of CTX-M-15 extended-spectrum beta-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait. Int J Antimicrob Agents. 2009;33(5):487–9. DOI: 10.1016/j.ijantimicag.2008.10.011.

Al-Agamy MH, Shibl AM, Tawfik AF. Prevalence and molecular characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann Saudi Med. 2009;29(4):253–7.

Yumuk Z, Afacan G, Nicolas-Chanoine MH, Sotto A, Lavigne JP. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. J Antimicrob Chemother. 2008;62(2):284–8. DOI: 10.1093/jac/dkn181.

Albert MJ, Rotimi VO, Dhar R, Silpikurian S, Pacsa AS, Molla AM, et al. Diarrhoeagenic Escherichia coli are not a significant cause of diarrhea in hospitalized children in Kuwait. BMC Microbiol. 2009;9:62. DOI: 10.1186/1471-2180-9-62.

Zonneveld A, Al Dhaheri K, Mag T, Herpay M, Kolodziejek J, Nowotny N, et al. CTX-M-15-producing multidrug-resistant enteroaggregative Escherichia coli in the United Arab Emirates. Clin Microbiol Infect. 2006;12(6):582–5. DOI: 10.1111/j.1469-0691.2006.01413.x.

Vignoli R, Varela G, Mota MI, Cordeiro NF, Power P, Ingold E, et al. Enteropathogenic Escherichia coli strains carrying genes encoding the PER-2 and TEM-116 extended-spectrum beta-lactamases isolated from children with diarrhea in Uruguay. J Clin Microbiol. 2005;43(6):2940–3. doi: 10.1128/JCM.43.6.2940-2943.2005.

Amaya E, Reyes D, Vilchez S, Paniagua M, Mollby R, Nord CE, et al. Antibiotic resistance patterns of intestinal Escherichia coli isolates from Nicaraguan children. J Med Microbiol. 2011;60(Pt 2):216–22. DOI: 10.1099/jmm.0.020842-0.

Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14(4):933–51. DOI: 10.1128/CMR.14.4.933-951.2001.

Ingram PR, Inglis TJ, Vanzetti TR, Henderson BA, Harnett GB, Murray RJ. Comparison of methods for AmpC beta-lactamase detection in Enterobacteriaceae. J Med Microbiol. 2011;60(Pt 6):715–21. DOI: 10.1099/jmm.0.029140-0.

Benenson S, Temper V, Cohen MJ, Schwartz C, Hidalgo-Grass C, Block C. Imipenem disc for detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice. J Clin Microbiol. 2011;49(4):1617–20. DOI: 10.1128/JCM.02179-10

Blanco M, Blanco JE, Dahbi G, Mora A, Alonso MP, Varela G, et al. Typing of intimin (eae) genes from enteropathogenic Escherichia coli (EPEC) isolated from children with diarrhea in Montevideo, Uruguay: identification of two novel intimin variants (muB and xiR/beta2B). J Med Microbiol. 2006;55(Pt 9):1165–74. doi: 10.1099/jmm.0.46518-0.

Kozub-Witkowski E, Krause G, Frankel G, Kramer D, Appel B, Beutin L. Serotypes and virutypes of enteropathogenic and enterohaemorrhagic Escherichia coli strains from stool samples of children with diarrhoea in Germany. J Appl Microbiol. 2008;104(2):403–10. doi: 10.1111/j.1365-2672.2007.03545.x.

Campos LC, Franzolin MR, Trabulsi LR. Diarrheagenic Escherichia coli categories among the traditional enteropathogenic E. coli O serogroups--a review. Mem Inst Oswaldo Cruz. 2004;99(6):545–52.

Nielsen JB, Albayati A, Jorgensen RL, Hansen KH, Lundgren B, Schonning K. An abbreviated MLVA identifies Escherichia coli ST131 as the major extended-spectrum beta-lactamase-producing lineage in the Copenhagen area. Eur J Clin Microbiol Infect Dis. 2013;32(3):431–6. doi: 10.1007/s10096-012-1764-x.

Naseer U, Olsson-Liljequist BE, Woodford N, Dhanji H, Canton R, Sundsfjord A, et al. Multi-locus variable number of tandem repeat analysis for rapid and accurate typing of virulent multidrug resistant Escherichia coli clones. PLoS One. 2012;7(7) doi: 10.1371/journal.pone.0041232.

Kanafani, Z. A., Dakdouki, G. K., El-Chammas, K. I., Eid, S., Araj, G. F., and Kanj, S. S. (2007). Bloodstreaminfections in febrile neutropenicpatients at a tertiary care center in Lebanon: a view of the past decade. Int. J. Infect. Dis. 11, 450–453. doi: 10.1016/j.ijid.2006.12.008

Zinner, S. H. (1999). Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin. Infect. Dis. 29, 490–494. doi: 10.1086/598620

Ramphal, R. (2004). Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin. Infect. Dis. 39, S25–S31. doi: 10.1086/383048

Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., et al. (2011). Infectious diseases society of america clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin. Infect. Dis. 52, 427–431. doi: 10.1093/cid/ciq147

Dettenkofer, M., Ebner, W., Bertz, H., Babikir, R., Finke, J., Frank, U., et al. (2003). Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation. Bone Marrow Transplant. 31, 795–801. doi: 10.1038/sj.bmt.1703920